CAS RN: 1260385-62-3
2-Bromobenzo[d]thiazol-4-ol
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g
- Available purity: ≥95%
- Inventory rows with stock: 3
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1260385-62-3
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
≥95% |
5
In Stock
|
Beijing |
Inquiry |
| 0.25g |
≥95% |
5
In Stock
|
Shanghai |
Inquiry |
| 1g |
≥95% |
1
In Stock
|
Beijing |
Inquiry |
1260385-62-3 / 2-bromo-1,3-benzothiazol-4-ol
Standard CAS: 1260385-62-3
Multi CAS: No
Basic Information
CAS
1260385-62-3
Multi CAS
No
Molecular Formula
C7H4BrNOS
Molecular Weight
230.080000
Exact Mass
228.919700
SMILES
C1=CC(=C2C(=C1)SC(=N2)Br)O
InChI
InChI=1S/C7H4BrNOS/c8-7-9-6-4(10)2-1-3-5(6)11-7/h1-3,10H
InChIKey
OVTAINLQDIHKSW-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
11
Aromatic heavy atom count
9
H-bond acceptors
3
H-bond donors
1
Molar refractivity
48.98
TPSA
33.12
LogP / Solubility
WLOGP
2.76
MLOGP
2.44
XLogP3
3
Consensus LogP
2.73
Log S (ESOL)
-3.61
Class (ESOL)
Poorly soluble
Log S (Ali)
-3.44
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-3.45
Class (SILICOS-IT)
Poorly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.16
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5